Author:
Tamburino Corrado,Ussia Gian Paolo
Reference236 articles.
1. Rahimtoola SH (2004) Aortic valve disease. In: Fuster V, Alexander RW, O’Ruourke RA (editors) Hurst’s the heart (11th ed.). McGraw Hill, New York, pp.1987–2000
2. Vahanian A, Baumgartner H, Bax J, et al (2007) Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 28:230–268
3. Olson M, Thyberg J, Nilsson J (1999). Presence of oxidized low-density lipoproteins in non rheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 19:1218
4. O’Brien KD, Shavelle DM, Caulfield MT, et al (2002). Association of ACE with low density lipoprotein in aortic valvular lesions and in human plasma. Circulation 106:2224–2230
5. Freeman RV, Otto CM (2005) Spectrum of calcific aortic valve disease: Pathogenesis, disease progression and treatment strategy. Circulation 111:3316–3326